Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  16 (2024)
Volume  15 (2023)
Volume  14 (2022)
Volume  13 (2021)
Volume  12 (2020)
Volume  11 (2019)
Volume  10 (2018)
Volume  9 (2017)
Volume  8 (2016)
Volume  7 (2015)
Volume  6 (2014)
Volume  5 (2013)
Volume  4 (2012)
Volume  3 (2011)
Volume  2 (2010)
Volume  1 (2009)
Related articles

VOLUME 15 , ISSUE 6 ( November-December, 2023 ) > List of Articles

ORIGINAL RESEARCH

Study of Maternal Blood Glucose Levels and Blood Count after Betamethasone Therapy in Preterm Pregnancy

Shaziya Azmathulla, Nandini Gopalakrishna, Jessica Celilna Fernandes, Kogali Suresh Shrichetan

Keywords : Betamethasone, Corticosteroids, Fasting blood glucose, Hyperglycemia, Postprandial blood glucose

Citation Information : Azmathulla S, Gopalakrishna N, Fernandes JC, Shrichetan KS. Study of Maternal Blood Glucose Levels and Blood Count after Betamethasone Therapy in Preterm Pregnancy. J South Asian Feder Obs Gynae 2023; 15 (6):675-678.

DOI: 10.5005/jp-journals-10006-2355

License: CC BY-NC 4.0

Published Online: 04-12-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Background: Premature birth is one of the largest problems in obstetrics today and the most significant cause of neonatal morbidity and mortality. An important complication of preterm birth is respiratory distress syndrome. Corticosteroids to the mother will help in accelerating the fetal lungs maturity. This study was undertaken to evaluate the blood sugar changes and white cell count in the mother, respectively, following antenatal corticosteroids. Objectives of the study: To evaluate changes in blood glucose levels, total leukocyte count, and differential count following betamethasone therapy in preterm labor. Materials and methods: A prospective cohort study was performed in women at 28–34 weeks of gestation with preterm labor receiving betamethasone. Fasting and postprandial blood sugar glucose values were obtained on days 2, 4, and 6 after betamethasone therapy from the day of admission. Total count (TC) and differential count (DC) were also measured on day 2 and day 4 from the day of admission. Results: In this study, FBS started rising from day 2 of betamethasone, with 93% having increased blood sugar. There was a significant change in FBS levels (p < 0.001) and PPBS levels (<0.001) following antenatal steroid therapy. Corticosteroid induced a significant neutrophilia and lymphocytopenia on day 2 following administration. Conclusion: Betamethasone resulted in an acute rise in fasting blood sugar and postprandial blood sugar, and leukocytosis is expected to peak in 24 hours, and the magnitude is small.

HTML PDF Share
  1. Arias F, Bhinde AG. Practical guide to high-risk pregnancy and delivery, a south Asian perspective. Preterm Birth. 4th edition, India. Elsevier Publications; 2015. pp. 135–137.
  2. Sharma JB. Textbook of obstetrics. Preterm Labour. 2nd edition. Avichal Publication Company; 2020.
  3. Misra R. Ian Donald's – Practical Obstetric Problems. Preterm Birth. 7th edition; 2014. pp. 409–410.
  4. Romero R, Dey SK, Fisher SJ. Preterm labor: One syndrome, many causes. Science; 2014;345(6198):760–765. DOI: 10.1126/science.1251816.
  5. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics. Practice Bulletin No. 172: Premature rupture of membranes. Obstet Gynecol 2016;128(4):el65–el77. DOI: 10.1097/AOG.0000000000001712.
  6. Howie RN, Liggins GC. The New Zealand study of antepartum glucocorticoid treatment in lung development. In: Farrell PM (ed.) Biological and Clinical Perspectives Vol II. Academic Press; 1982. pp. 255–265.
  7. Yehuda R, Fairman KR, Meyer JS. Enhanced brain cell proliferation following early adrenalectomy in rats. J Neurochem 1989;53(1): 241–248. DOI: 10.1111/j.1471-4159.1989.tb07320.x.
  8. Meyer JS. Early adrenalectomy stimulates subsequent growth and development of the rat brain. Exp Neural 1983;82(2):432–446. DOI: 10.1016/0014-4886(83)90415-6.
  9. Harris A, Seckl J. Glucocorticoids, prenatal stress and the programming of disease. Horm Behav 2011;59(3):279–289. DOI: 10.1016/j.yhbeh.2010.06.007.
  10. Kemp MW, Newnham JP, Challis JG, et al. The clinical use of corticosteroids in pregnancy. Hum Reprod Update 2016;22(2): 240–259. DOI: 10.1093/humupd/dmv047.
  11. Bauer ME, Price LK, MacEachern MP, et al. Maternal leukocytosis after antenatal corticosteroid administration: A systematic review and meta-analysis. J Obstet Gynaecol 2017;38(2):210–216. DOI: 10.1080/01443615.2017.1342614.
  12. Hwang JL, Weiss RE. Steroid-induced diabetes: A clinical and molecular approach to understanding and treatment. Diabetes Metab Res Rev 2014;30(2):96–102. DOI: 10.1002/dmrr.2486.
  13. Denison FC, Elliott CL, Wallace EM. Dexamethasone-induced leukocytosis in pregnancy. Br J Obstet Gynaecol 1997;104(7):851–853. DOI: 10.1111/j.1471-0528.1997.tb12035.x.
  14. Wallace EM, Ekkel K, Cotter T, et al. Hematological effects of betamethasone treatment in late pregnancy. Aust N Z J Obstet Gynecol 1998;38(4):396–398. DOI: 10.1111/j.1479-828x.1998.tb03095.x.
  15. Vaisbuch E, Levy R, Hagay Z. The effect of betamethasone administration to pregnant women on maternal serum indicators of infection. J Perinat Med 2002;30(4):287–291. DOI: 10.1515/JPM.2002.041.
  16. Diebel ND, Parsons MT, Spellacy WN. The effects of betamethasone on white blood cells during pregnancy with PPROM. J Perinat Med 1998;26(3):204–207. DOI: 10.1515/jpme.1998.26.3.204.
  17. Langen ES, Kuperstock JL, Sung JF, et al. Maternal glucose response to betamethasone administration. Am J Perinatol 2015;30(2):143–148. DOI: 10.1055/s-0034-1376387.
  18. Lee SE, Park JS, Norwitz ER, et al. Measurement of placental alpha-microglobulin-1 in cervicovaginal discharge to diagnose rupture of membranes. Obstet Gynecol 2007;109(3):634–640. DOI: 10.1097/01.AOG.0000252706.46734.0a.
  19. Cunningham FG, Gant NF, Leveno KJ. Williams's Obstetrics, Preterm. 25th edition. United States: McGraw-Hill Education; 2018. pp. 803–809.
  20. Gardosi J. Customized fetal growth standards: Rationale and clinical application. Semin Perinatol 2004;28(1):33–40. DOI: 10.1053/j.semperi.2003.12.002.
  21. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972:50(4);515–525. PMID: 4561295.
  22. Sakonidou S, Dhaliwal J. The management of neonatal respiratory distress syndrome in preterm infants (European Consensus Guidelines–2013 update). Arch Dis Child Educ Pract Ed 2015;100(5): 257–259. DOI: 10.1136/archdischild-2014-306642.
  23. Fernandes SF, D'Cunha RJ, D'Almeida J. A study on the effect of antenatal corticosteroids on glycemic response in preterm patients. J South Asian Federation Obstet Gynaecol 2022;14(2):148–151. DOI: 10.5005/jp-journals-10006-2016.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.